04/22/2024
3:33 PM | Acumen Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
3:30 PM | Acumen Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2024
3:31 PM | Acumen Pharmaceuticals (Filer)
| Form DEFA14A | |
03/27/2024
3:34 PM | Acumen Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/27/2024
3:34 PM | Acumen Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/26/2024
8:16 AM | Acumen Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/19/2024
7:05 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:32 AM | Acumen Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/06/2024
8:02 AM | Acumen Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G | |
02/01/2024
4:01 PM | Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/01/2024
4:02 PM | Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:16 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
3:22 PM | Acumen Pharmaceuticals (Subject)
MURRAY JAMES B JR (Filed by)
| Form SC 13G/A | |
01/19/2024
6:04 PM | Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:05 PM | Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:05 PM | Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:06 PM | Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:07 PM | Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:35 PM | Acumen Pharmaceuticals (Subject)
OConnell Daniel Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
3:36 PM | Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:27 PM | Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:28 PM | Acumen Pharmaceuticals (Subject)
Barton Russell (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:29 PM | Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
7:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:33 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:20 PM | Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:21 PM | Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:22 PM | Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:23 PM | Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:18 PM | Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
6:45 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:20 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
5:31 PM | Acumen Pharmaceuticals (Issuer)
Ives Jeffrey L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
10:46 AM | Acumen Pharmaceuticals (Subject)
Ives Jeffrey L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023
6:33 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
3:49 PM | Acumen Pharmaceuticals (Filer)
| Form 424B5 | |
07/17/2023
3:44 PM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
5:06 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:21 PM | Acumen Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:40 PM | Acumen Pharmaceuticals (Issuer)
Drapkin Kimberlee C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
06/07/2023
4:42 PM | Acumen Pharmaceuticals (Issuer)
Fountain Nathan B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:43 PM | Acumen Pharmaceuticals (Issuer)
Ives Jeffrey L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:43 PM | Acumen Pharmaceuticals (Issuer)
Porter Derrell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:44 PM | Acumen Pharmaceuticals (Issuer)
Stoppel Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:45 PM | Acumen Pharmaceuticals (Issuer)
Stalfort John A III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
6:08 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/27/2023
3:26 PM | Acumen Pharmaceuticals (Filer)
| Form ARS | |
04/27/2023
6:02 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/27/2023
6:06 AM | Acumen Pharmaceuticals (Filer)
| Form 424B5 | |
